Accelerating compliance
and approvals with unmatched regulatory insight and experience.

Contact Us Today
The Lachman Difference

The most efficient services.
The most qualified professionals.

Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA consultants and industry experts has offered compliance, regulatory affairs, and science & technology services to clients around the world.

Learn More About Us

Stay in the know

Sign up today for the Lachman Consultants blog.

Get the latest news on industry compliance, regulatory affairs, technical services, and a whole lot more.

    AREAS SERVED BY LACHMAN CONSULTANTS

    ADVANCE. CONFIDENTLY.

    As long-standing leaders in technical and regulatory consulting services, Lachman Consultants provides both experience and excellence through an unmatched team of respected industry professionals and SMEs.

    Mock FDA Audits

    Are you fully prepared for an inspection at your facility?

    Our team of experienced ex-FDA investigators offer comprehensive Mock FDA Audit services to help you prepare for an actual FDA inspection. Our team of experts will conduct a thorough inspection of your facility, review your documentation, and provide you with valuable feedback on areas that need improvement to ensure compliance with FDA regulations – both remotely and on-site.

    Learn More About Mock FDA Audits

    OnCall Image

    Recent Posts

    The Lachman Consultants Blog

    The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.

    Change At the Top at OGD!

    This morning, I was perusing the agenda for the upcoming GRx-Biosims 2...
    Read More
    A New Morale Hit at FDA on Employee Performance Evaluation

    A New Morale Hit at FDA on Employee Performance Evaluation

    According to a Pink Sheet article written by Maaisha Osman here (subsc...
    Read More

    The Question for AI: Not “Does It Work?” but “Can You and FDA Find It Trustworthy?”

    I sat in on the AI session at ARM's Cell & Gene Meeting on the Mes...
    Read More

    Great Science Isn’t Enough: Shared Insights by the CBER Director at ARMs Meeting on the Mesa

    On Monday morning at the Arizona Biltmore in Phoenix, Karim Mikhail op...
    Read More
    FDA Official August 2026 Monthly Stat Report and Unofficial September Approval Numbers

    FDA Official August 2026 Monthly Stat Report and Unofficial September Approval Numbers

    With the official August 2026 numbers reported, let’s take a walk on...
    Read More
    FDA Looks for Comments on Ibogaine Potential Study Safety Guardrails.

    FDA Looks for Comments on Ibogaine Potential Study Safety Guardrails.

    The FDA is asking for comments on how the early-phase clinical trials ...
    Read More
    ADVANCE CONFIDENTLY
    Contact Us Today